Sagimet Biosciences, Inc.: Strategic Advancements and Financial Robustness Drive Buy Rating
Sagimet Biosciences, Inc. Class A (SGMT) has received a new Buy rating, initiated by TD Cowen analyst, Ritu Baral. Ritu Baral has given her Buy ...